H-1B sponsorship profile: ReCode Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, ReCode Therapeutics, Inc filed 12 Labor Condition Applications covering 12 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (12 certified of 12 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on ReCode Therapeutics, Inc’s H-1B petitions range from $76,000 at the low end to $185,000 at the high end, with a petition-weighted average of $118,269. That range reflects the mix of occupations the company sponsors, led by Scientist II (3 petitions at $136,667 avg), followed by Senior Research Associate I, Gene Editing and Senior Research Associate I. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. ReCode Therapeutics, Inc is headquartered in Menlo Park, CA under NAICS code 541715, and places H-1B workers across 2 states, most heavily in CA, TX. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where ReCode Therapeutics, Inc ranks. By H-1B petition volume, ReCode Therapeutics, Inc is #14,627 of 119,880 employers nationally and #2,274 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.